Introduction
Cardiovascular disease (CVD) is one of the leading causes of death globally, and the associated morbidity and mortality is rapidly increasing in China. 1 Poor pulmonary function has been linked to a higher risk of CVD in previous studies. [2] [3] [4] This may result from an induced systemic inflammatory response, leading to endothelial dysfunction or vascular alterations that are characterized by increase in vascular permeability and formation of plaques. 2 Common carotid artery (CCA) intima-medial thickness (IMT) and the presence of carotid plaques are well accepted surrogate markers for atherosclerosis. However, the results describing the association of poor pulmonary function with thicker carotid IMT are inconsistent. [5] [6] [7] [8] [9] [10] [11] As smoking causes both chronic obstructive pulmonary disease (COPD) 12 and atherosclerosis, 13, 14 some studies showed that the association between pulmonary function and atherosclerosis varied by smoking status. 5, [15] [16] [17] For example, the Atherosclerosis Risk in Communities (ARIC) Study showed that poor pulmonary function was significantly associated with atherosclerosis in smokers but not in never smokers. 5 Other studies, such as the Etude sur le Vieillissement Artériel study 6 and the Multi-Ethnic Study of Atherosclerosis Study (MESA), 18 reported a significant association of poor pulmonary function with atherosclerosis in both smokers and never smokers. Whether the association between pulmonary function and atherosclerosis varies by smoking status is unclear.
Few studies have assessed the association of pulmonary function with carotid atherosclerosis in Chinese populations. We found only one study from China showing a significant association of poor pulmonary function and higher IMT. 19 In that study, low forced expiratory volume in 1 second (FEV 1 )
but not low forced vital capacity (FVC) was associated with a thicker carotid IMT in smokers. 19 However, whether the association of pulmonary function with carotid plaque varies by smoking status was not assessed. 19 Hence, we examined the association of poor pulmonary function with carotid atherosclerosis in an older Chinese sample from the Guangzhou Biobank Cohort Study-CVD Subcohort.
Methods

Study participants
Details of the Guangzhou Biobank Cohort Study (GBCS) have been described elsewhere. 20 Briefly, it is a three-way collaboration among the Guangzhou Number 
Exposures
Spirometry was done by a turbine flowmeter (Cosmed microQuark, Rome, Italy), and we had described the details elsewhere. 22 The pulmonary function test was conducted in a standing position following standard procedures, with at least three maneuvers and the best measure of FEV 1 
Study outcomes
CCA-IMT and carotid artery plaque, measured by B-mode ultrasonography, are non-invasive quantitative measures of the presence and severity of carotid atherosclerosis. 24 We had reported the details of these measures elsewhere. 21, 25, 26 Briefly, the participants had carotid B-mode ultrasonographic examination using ALT HDI 3000 mainframe with a high-resolution, linear array scanner (medium frequency 7.5 MHz), performed by a registered specialist physician. All scans were performed following a predetermined, standardized scanning protocol for the right and left carotid arteries using images of the far wall of the distal 10 mm of the common carotid arteries. Three scanning angles, with the image focused on the posterior wall, were recorded from the angle showing the greatest distance between the lumen-intima interface and the media-adventitia interface. All scans were analyzed by the same physician, blinded to subjects' information. When thicker CCA-IMT or carotid plaque were observed, at least two physicians, including one chief physician, discussed and made the final decision by consensus.
The thickest measures of the left and right bilateral CCA-IMT were obtained, and the means used in the analyses. The presence of thickened CCA-IMT was diagnosed when one or both of the left or right CCA-IMT was ≥1.0mm. 27 A plaque was defined as a distinct area protruding ≥1.2mm into the vascular lumen of the carotid artery. 28 Participants with one or more plaques in the CCA, internal carotid arteries or bifurcations of carotid arteries, on the right or left side were categorized as having carotid plaque. The pulmonary function tests and the measurements of vascular morphological parameters were conducted during the same visit.
Statistical analysis
Continuous variables were analyzed using independent sample t-test and categorical variables using We tested for interaction between pulmonary function and sex/smoking using likelihood ratio test to test for the fitness of models with or without the interaction terms. Models with a lower Akaike information criterion (AIC) value indicate better fitness. We also performed analysis examining the association of pulmonary function with atherosclerosis by sex or smoking status as sensitivity analysis. All tests of significance were 2-tailed, with p <0.05 as statistically significant. All analyses were performed using SPSS version 19.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Of 1996 participants in the GBCS-CVD Subcohort, 1625 (81%) participants with all the information of interest were included in the current analyses. The mean age was 59.4 years (standard deviation, 6.8). Half of the participants were women (49.5%) and 9.7% had COPD. Table 1 shows that compared to those without COPD, those with COPD were older, had lower socioeconomic position (lower education and more manual occupation), were less physically active, and more likely to be men and smokers, and tended to have poor self-rated health and hypertension. They also had higher hs-CRP, systolic blood pressure, CCA-IMT levels and a higher prevalence of carotid plaque, but had lower BMI and lipids (all P <0.05 except for HDL-cholesterol).
We found no evidence that the association of pulmonary function with carotid atherosclerosis (presence of carotid plaque or thickened CCA-IMT) varied by sex or smoking status (P values for sex interaction: 0.17-0.57, and for smoking interaction: 0.23-0.83). Hence, all analyses were conducted in men and women together with adjustment for sex and smoking. Table 2 (Table 4) . Generally, the association of poorer pulmonary function with carotid atherosclerosis showed dose-response relationships (P values for trend ranged from <0.001 to 0.005).
Stratified analysis by smoking status (Appendix Tables 1 and 2 ) and sex (Appendix Tables 3 and 4) showed similar results. Compared to participants in the highest tertile of FEV 1 observed to predicted ratio, the adjusted OR of thickened CCA-IMT for those in the lowest tertile of FEV 1 observed to predicted ratio was 3.00 (95% CI 1.58-5.71) in ever smokers and 1.47 (95% CI 0.83-2.59; P =0. 18) in never smokers (Appendix Table 1 Table 3 ). The adjusted ORs of thickened CCA-IMT by FVC observed to predicted ratio were similar in ever smokers (OR 1.77, 95% CI 0.95-3.29, P =0.07) and never smokers (OR 1.98, 95% CI 1.07-3.65, P =0.03), but seemed to be higher in women than men (3.41, 95% CI 1.22-9.55, and 1.52, 95% CI 0.93-2.49, P =0.10, respectively) (Appendix Tables 2 and   4 ).
Discussion
Our study showed that poorer pulmonary function, indicated by COPD, lower FEV 1 and FVC, was dose-dependently associated with thickened CCA-IMT and carotid plaque. Furthermore, we found no evidence that the associations varied by sex or smoking status with significant associations being found in both never and ever smokers as well as in both sexes. 17 Similarly, most of the previous studies reported significant association of lower FVC observed to predicted ratio and FEV 1 /FVC ratio with carotid IMT. 18, 19 Whether the association varied by smoking status was unclear.
One study of 3642 participants showed that, when stratified by smoking status, no association of FVC with CCA or ICA-IMT in smokers was found. 18 The major limitation of this study was the lack of concurrent measures with the lung function being assessed about 4 years after the measures of carotid atherosclerosis.
Few studies have assessed the association between pulmonary function and carotid IMT in Chinese populations. We found only one study by Ma et al. which showed that lower FVC observed to predicted ratio and FEV 1 observed to predicted ratio were significantly associated with thicker IMT in all participants and in never smokers after adjustment for potential confounders. 19 Only FEV 1 observed to predicted ratio, but not FVC observed to predicted ratio, was associated with carotid IMT in smokers, probably because of the small number of smokers (n=74 in the 4 th quartile).
Moreover, due to the limited sample size, the authors did not assess the interaction of smoking categories with lung function. Our findings extended the observations from Ma's study and further showed dose-response relationships of poorer pulmonary function with thickened CCA-IMT in both never smokers and ever smokers.
In our study, we found no evidence that the association between pulmonary function and carotid atherosclerosis varied by sex. Few studies examined sex interaction, and for those that did, the results were mixed. 5, 6 A study of 656 older French people found significant associations between lung function and atherosclerosis in both men and women, and the associations did not vary by sex (P=0.91). 6 However, another study of 14000 American participants found that the association was stronger in women than in men among never smokers (P for sex interaction <0.001). 5 Taken together, whether the association of lung function and atherosclerosis varies by sex or depends on some sex-specific factors remains unclear.
Lung inflammation due to COPD may lead to a systemic inflammatory response with increase in circulating leukocytes, platelets, cytokines, and acute-phase proteins. 2 These mediators activate the vascular endothelium, causing endothelial dysfunction which is characterized by reduced vasodilatation with decreased nitric oxide (NO) and increased endothelin (ET) expression; increased vascular permeability and the uptake of oxidized low-density lipoproteins (LDL) promoting the development of atherosclerotic plaque. 2 A ventilation/perfusion mismatch associated with impaired pulmonary function and a systemic inflammatory response have been proposed as the mechanisms for this association. 2 A lower ventilation/perfusion ratio due to impaired lung function may result in chronic arterial wall hypoxia. 32 Arterial medial hypoxia might stimulate release of growth factors and cytokines which may initiate a series of changes including macrophage migration and activation, increased endothelial permeability, and platelet adherence and degranulation, intimal and adventitial proliferation that decreases trans-intimal oxygen delivery. 32 Ultimately, a pathophysiological positive feedback loop is completed and the atherosclerosis is resulted. 32 Moreover, Sabater-Lleal et al. described genetic factors (i.e., rs9978142 and rs3995090 located in the HTR4 gene) that were implicated in determining human lung function also influenced carotid IMT supporting a molecular basis of the co-localization of these co-morbidities. 33 Independently from the common vascular risk factors, common genetic pathways existing between impaired lung function and atherosclerosis could be the fundamental mechanism for this association. 33 Ventilation/perfusion mismatch and systemic inflammation might exacerbate this association. 2 There were several limitations in our study. Common to all such cohorts, as our participants being older and therefore survivors, healthy volunteer bias could not be fully ruled out. The number of participants with airflow limitation and smokers was relatively small and we did not perform post-bronchodilator spirometry. However, all earlier population-based studies on pulmonary function and cardiovascular risk were similarly based on pre-bronchodilator spirometry measurements. 34 We also could not ascertain the time sequences between changes in pulmonary function and the vascular morphological parameters. Some of the potential confounders could also be mediators, and the multivariate adjustment could have led to an underestimation of the true effect, although that would have been more of an issue had we not observed such associations. Similarly, our sample size could be insufficient to test small interaction effects, but again given the associations in the sex-specific analyses and in never and ever smokers were similar, this is unlikely to be a major issue. Finally, residual confounding could not be fully ruled out. For instance, non-occupational environmental dust exposure might adversely contribute to both vascular and pulmonary function. 35 Renal function (estimated glomerular filtration rate) and other determinants of IMT (e.g. serum uric acid) might also confound the observed association. 36 Further studies need to consider these factors to clarify the most important factors directly involved in the disease aetiology. The causal association between pulmonary function and carotid atherosclerosis could not be confirmed in this cross-sectional analysis.
In conclusion, we found that poorer pulmonary function was associated with higher risk of carotid atherosclerosis after adjusting for multiple potential confounders including smoking, and the association did not vary by sex or smoking status. Given the relatively small sample and cross-sectional nature of our study, further large prospective studies are warranted. If our results were confirmed, subclinical atherosclerosis screening in people with poor pulmonary function may identify those at high risk of atherosclerosis and measures to prevent further progress and complications would be needed. 1.00 0.98 FVC, forced vital capacity; CCA-IMT, common carotid artery intima-median thickness; Model 1: Adjusted for sex, age, education, occupation, drinking, occupational dust exposure, self-rated health and physical activity. Model 2: Additionally adjusted for body mass index, high-sensitivity C-reactive protein, LDL-cholesterol, triglycerides, systolic blood pressure and diabetes. Thickened CCA-IMT: CCA-IMT ≥1.0mm P for smoking interaction (ever smokers vs. never smokers): (1) thickened CCA-IMT: 0.83; (2) carotid plaque: 0.57 *P<0.05; **P<0.01
